Nocturnal hypercapnia with daytime normocapnia in patients with advanced pulmonary arterial hypertension awaiting lung transplantation

• Published in: PloS one 2020-04, Vol.15 (4), p.e0227775-e0227775
• Main Authors: Nakatsuka, Yoshinari, Chen-Yoshikawa, Toyofumi, Kinoshita, Hideyuki, Aoyama, Akihiro, Kubo, Hiroyasu, Murase, Kimihiko, Hamada, Satoshi, Takeyama, Hirofumi, Minami, Takuma, Takahashi, Naomi, Tanizawa, Kiminobu, Handa, Tomohiro, Hirai, Toyohiro, Date, Hiroshi, Chin, Kazuo
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Biology and Life Sciences; Carbon dioxide; Carbon Dioxide - blood; Cardiac output; Catheterization; Child; Congenital diseases; Daytime; Evaluation; Familial Primary Pulmonary Hypertension - blood; Familial Primary Pulmonary Hypertension - complications; Familial Primary Pulmonary Hypertension - surgery; Female; Heart; Hemodynamics; Hospitals; Humans; Hypercapnia; Hypercapnia - blood; Hypercapnia - diagnosis; Hypercapnia - epidemiology; Hypercapnia - etiology; Hypertension; Hypoxia; Intubation; Japan - epidemiology; Lung Transplantation; Lungs; Male; Medicine; Medicine and Health Sciences; Middle Aged; Partial pressure; Pathogenesis; Patients; Polysomnography; Prevalence; Pulmonary Arterial Hypertension - complications; Pulmonary Arterial Hypertension - diagnosis; Pulmonary Arterial Hypertension - surgery; Pulmonary arteries; Pulmonary functions; Pulmonary hypertension; Respiratory function; Retrospective Studies; Severity of Illness Index; Sleep; Sleep Apnea Syndromes - blood; Sleep Apnea Syndromes - diagnosis; Sleep Apnea Syndromes - epidemiology; Sleep Apnea Syndromes - etiology; Surgery; Therapeutic applications; Thoracic surgery; Transplantation; Waiting Lists; Young Adult
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0227775

Pulmonary arterial hypertension (PAH) is frequently complicated by sleep disordered breathing (SDB), and previous studies have largely focused on hypoxemic SDB. Even though nocturnal hypercapnia was shown to exacerbate pulmonary hypertension, the clinical significance of nocturnal hypercapnia among PAH patients has been scarcely investigated. Seventeen patients with PAH were identified from 246 consecutive patients referred to Kyoto University Hospital for the evaluation of lung transplant registration from January 2010 to December 2017. Included in this study were 13 patients whose nocturnal transcutaneous carbon dioxide partial pressure (PtcCO2) monitoring data were available. Nocturnal hypercapnia was diagnosed according to the guidelines of the American Academy of Sleep Medicine. Associations of nocturnal PtcCO2 measurements with clinical features, the findings of right heart catheterization and pulmonary function parameters were evaluated. Nocturnal hypercapnia was diagnosed in six patients (46.2%), while no patient had daytime hypercapnia. Of note, nocturnal hypercapnia was found for 5 out of 6 patients with idiopathic PAH (83.3%). Mean nocturnal PtcCO2 levels correlated negatively with the percentage of predicted total lung capacity (TLC), and positively with cardiac output and cardiac index. Nocturnal hypercapnia was prevalent among advanced PAH patients who were waiting for lung transplantation, and associated with %TLC. Nocturnal hypercapnia was associated with the increase in cardiac output, which might potentially worsen pulmonary hypertension especially during sleep. Further studies are needed to investigate hemodynamics during sleep and to clarify whether nocturnal hypercapnia can be a therapeutic target for PAH patients.